Malignant Melanoma Terminated Phase 1 / 2 Trials for Cyclophosphamide (DB00531)

Also known as: Melanoma, Malignant / [M]Malignant melanoma NOS / Melanoma / Melanoma malignant

IndicationStatusPhase
DBCOND0029825 (Malignant Melanoma)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02153905T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 PositiveTreatment
NCT00924001Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic MelanomaTreatment